Addus HomeCare Co. (NASDAQ:ADUS) Receives $142.57 Consensus Target Price from Analysts

Addus HomeCare Co. (NASDAQ:ADUS - Get Free Report) has been given a consensus recommendation of "Buy" by the eight ratings firms that are presently covering the company, MarketBeat.com reports. Six equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $142.57.

A number of brokerages recently issued reports on ADUS. Wall Street Zen cut Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. JMP Securities reissued a "market outperform" rating and set a $150.00 price objective on shares of Addus HomeCare in a report on Tuesday, April 22nd. Macquarie increased their price target on shares of Addus HomeCare from $129.00 to $133.00 and gave the company an "outperform" rating in a research report on Thursday, May 8th. Finally, Stephens reaffirmed an "overweight" rating and issued a $142.00 price target on shares of Addus HomeCare in a research note on Wednesday, March 12th.

Addus HomeCare Trading Up 0.3%

NASDAQ:ADUS traded up $0.29 on Friday, reaching $111.49. 86,198 shares of the stock traded hands, compared to its average volume of 168,749. The firm has a market capitalization of $2.05 billion, a price-to-earnings ratio of 25.51, a price-to-earnings-growth ratio of 1.41 and a beta of 0.85. The company's 50 day moving average is $104.75 and its 200-day moving average is $112.61. Addus HomeCare has a 1-year low of $88.96 and a 1-year high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.42 EPS for the quarter, topping the consensus estimate of $1.33 by $0.09. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company had revenue of $337.71 million during the quarter, compared to the consensus estimate of $341.66 million. During the same quarter last year, the firm posted $1.21 EPS. The company's quarterly revenue was up 20.3% on a year-over-year basis. On average, equities research analysts forecast that Addus HomeCare will post 4.59 EPS for the current fiscal year.

Insider Buying and Selling at Addus HomeCare

In related news, EVP Michael D. Wattenbarger sold 2,045 shares of the firm's stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total value of $235,175.00. Following the completion of the sale, the executive vice president now directly owns 7,796 shares in the company, valued at $896,540. This trade represents a 20.78% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 4.60% of the company's stock.

Institutional Investors Weigh In On Addus HomeCare

A number of institutional investors have recently added to or reduced their stakes in ADUS. Barclays PLC lifted its holdings in shares of Addus HomeCare by 204.8% during the third quarter. Barclays PLC now owns 43,470 shares of the company's stock worth $5,783,000 after purchasing an additional 29,207 shares during the period. Janney Montgomery Scott LLC boosted its stake in shares of Addus HomeCare by 0.9% in the fourth quarter. Janney Montgomery Scott LLC now owns 10,691 shares of the company's stock worth $1,340,000 after acquiring an additional 91 shares during the last quarter. KBC Group NV boosted its stake in shares of Addus HomeCare by 49.1% in the fourth quarter. KBC Group NV now owns 814 shares of the company's stock worth $102,000 after acquiring an additional 268 shares during the last quarter. Empowered Funds LLC boosted its stake in shares of Addus HomeCare by 31.3% in the fourth quarter. Empowered Funds LLC now owns 18,227 shares of the company's stock worth $2,285,000 after acquiring an additional 4,340 shares during the last quarter. Finally, Equitable Trust Co. boosted its stake in shares of Addus HomeCare by 47.1% in the fourth quarter. Equitable Trust Co. now owns 7,096 shares of the company's stock worth $889,000 after acquiring an additional 2,271 shares during the last quarter. Institutional investors own 95.35% of the company's stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.